Showing results (711-720 of 919) with videos related to
Sort By:
Pageof 92
Annals of Internal Medicine|July 15, 1994
Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement surgery. Enoxaparin Clinical Trial GroupT E Spiro, G J Johnson, M J Christie, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 21, 2005
Glucocorticoid administration reduces cardiac dysfunction after brain death in pigsJefferson M Lyons, Jeffrey M Pearl, Kelly M McLean, et al.Diabetes|July 2, 1999
Effects of glucose intolerance on myocardial function and collagen-linked glycationG F Avendano, R K Agarwal, R I Bashey, et al.The Annals of Thoracic Surgery|March 3, 2004
Preoperative glucocorticoids decrease pulmonary hypertension in piglets after cardiopulmonary bypass and circulatory arrestJeffrey M Pearl, Steven M Schwartz, David P Nelson, et al.BMC Cancer|March 22, 2022
Expression of the preadipocyte marker ZFP423 is dysregulated between well-differentiated and dedifferentiated liposarcomaThanh N Dang, Rafael P Tiongco, Loren M Brown, et al.Journal of Crohn'S & Colitis|June 27, 2019
Systemic Molecular Mediators of Inflammation Differentiate Between Crohn's Disease and Ulcerative Colitis, Implicating Threshold Levels of IL-10 and Relative Ratios of Pro-inflammatory Cytokines in TherapyMiranda G Kiernan, J Calvin Coffey, Shaheel M Sahebally, et al.International Journal of Molecular Sciences|November 27, 2021
MVP Expression Facilitates Tumor Cell Proliferation and Migration Supporting the Metastasis of Colorectal Cancer CellsPaulina Pietras, Marta Leśniczak-Staszak, Aldona Kasprzak, et al.ACS Applied Bio Materials|January 13, 2022
Superhydrophobic Surfaces as a Source of Airborne Singlet Oxygen through Free Space for Photodynamic TherapyDavid Aebisher, Dorota Bartusik-Aebisher, Sarah J Belh, et al.Nature Genetics|January 4, 2001
Bone morphogenetic protein-3 is a negative regulator of bone densityA Daluiski, T Engstrand, M E Bahamonde, et al.Journal of Hematology & Oncology|November 30, 2012
A randomized, double-blind, placebo-controlled phase 2 study evaluating the efficacy and safety of romiplostim treatment of patients with low or intermediate-1 risk myelodysplastic syndrome receiving lenalidomideEunice S Wang, Roger M Lyons, Richard A Larson, et al.Pageof 92